封面
市场调查报告书
商品编码
1690365

血糖监测系统市场报告:2031 年趋势、预测与竞争分析

Blood Glucose Monitoring System Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球血糖监测系统市场前景光明,指尖和替代站点市场充满机会。预计到 2031 年,全球血糖监测系统市场规模将达到 371 亿美元,2025 年至 2031 年的复合年增长率为 7.5%。这个市场的主要驱动因素是糖尿病盛行率的上升、人口老化导致的糖尿病易感性增加、新产品的发布以及人们对糖尿病预防意识的不断提高。

  • Lucintel 表示,基于患者护理环境,由于糖尿病患者数量的增加以及人们对定期血糖监测的认识的提高,预计居家医疗在预测期内仍将是最大的细分市场。
  • 在测试站点类别中,指尖测试由于其高准确性和可靠性预计将继续占据最大的份额。
  • 根据地区划分,由于肥胖率上升、医疗保健成本高、新产品推出以及技术进步,预计北美在预测期内仍将是最大的地区。

血糖监测系统市场的策略性成长机会

从策略角度来看,血糖监测系统市场在关键应用领域提供了许多成长机会。摘要如下:

  • 糖尿病管理:糖尿病管理:采用先进的血糖监测系统进行糖尿病管理带来了成长机会。这些系统提供即时资料和见解,以更好地管理和治疗糖尿病。
  • 与远端医疗的整合:将血糖监测系统与远端医疗平台结合也可以开闢成长前景。这使得远端监控和咨询成为可能,从而提高了护理品质和患者管理。
  • 提供可负担的监测解决方案:为低收入和发展中地区开发可负担的血糖监测设备代表着一个巨大的成长机会。这些解决方案将扩大糖尿病管理工具的使用范围并改善全球健康。
  • 穿戴式科技:将血糖监测系统与穿戴式科技结合,开启了成长潜力。穿戴式装置支援持续血糖监测以及其他健康指标,促进全面的健康管理。
  • 个人化医疗:血糖监测资料具有成长机会,可支援个人化医疗。根据个人血糖模式和反应制定糖尿病管理方案可提高治疗效果和患者预后。

这些新机会正在推动市场成长和发展,提高血糖监测系统的有效性和采用率。

血糖监测系统市场驱动因素与挑战

血糖监测系统市场是一个不断成长的市场,其成长潜力受到各种技术、经济和监管因素的影响。以下是一些关键驱动因素和挑战:

推动血糖监测系统市场发展的因素有:

  • 技术进步:CGM 和非侵入性血糖监测技术的改进和创新提高了使用者的准确性和便利性。这推动了市场的成长。
  • 糖尿病盛行率不断上升:全球糖尿病盛行率的上升推动了对有效血糖监测解决方案的需求成长,进一步促进了市场扩张。
  • 融入数位健康:血糖监测仪越来越多地融入数位健康平台,增强资料管理和病人参与,从而支持市场成长。
  • 专注于个人化:个人化医疗和个人化治疗计划的进步推动了对先进血糖监测系统的需求。
  • 经济实惠的解决方案:具有成本效益的血糖监测设备的开发正在扩大市场准入并刺激服务不足地区的成长。

血糖监测系统市场面临的挑战是:

  • 高成本:先进的血糖监测系统价格昂贵,采用有限,尤其是在低收入和用户人群中。
  • 监管障碍:获得新技术的核准可能很复杂且耗时,这可能会延迟产品发布和市场进入。

这些市场驱动因素和挑战将继续影响血糖监测系统市场,塑造其成长轨迹和相关人员的策略决策。

目录

第一章执行摘要

第二章全球血糖监测系统市场:市场动态

  • 简介、背景和分类
  • 供应链
  • 产业驱动力与挑战

第三章市场趋势与预测分析(2019-2031)

  • 宏观经济趋势(2019-2024)及预测(2025-2031)
  • 全球血糖监测系统市场趋势(2019-2024)及预测(2025-2031)
  • 全球血糖监测系统市场(按测试站点)
    • 指尖
    • 替代网站
  • 全球血糖监测系统市场(按产品)
    • 自我监控
    • 连续血糖监测装置
  • 全球血糖监测系统市场(依病患照护环境)
    • 医院
    • 居家医疗
  • 全球血糖监测系统市场(按应用)
    • 1型糖尿病
    • 2型糖尿病
    • 妊娠糖尿病
    • 其他的

第四章区域市场趋势与预测分析(2019-2031)

  • 全球血糖监测系统市场(按地区)
  • 北美血糖监测系统市场
  • 欧洲血糖监测系统市场
  • 亚太血糖监测系统市场
  • 世界其他地区血糖监测系统市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球血糖监测系统市场成长机会(按测试站点)
    • 全球血糖监测系统市场成长机会(按产品)
    • 全球血糖监测系统市场的成长机会(依病患照护环境)
    • 全球血糖监测系统市场成长机会(按应用)
    • 全球血糖监测系统市场各区域成长机会
  • 全球血糖监测系统市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球血糖监测系统市场产能扩张
    • 全球血糖监测系统市场的企业合併
    • 认证和许可

第七章主要企业简介

  • Thermos Fisher Scientific
  • Promega
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • BD
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott
简介目录

The future of the global blood glucose monitoring system market looks promising with opportunities in the fingertip and alternate site markets. The global blood glucose monitoring system market is expected to reach an estimated $37.1 billion by 2031 with a CAGR of 7.5% from 2025 to 2031. The major drivers for this market are the growing prevalence of diabetes, the aging population's increased susceptibility to the disease, as well as, raising awareness of new product releases and diabetes prevention.

  • Lucintel forecasts that, within the patient care setting category, homecare will remain the largest segment over the forecast period due to the rising number of diabetic patients and increasing awareness about regular monitoring of glucose levels.
  • Within the testing site category, fingertip testing will remain the largest segment due to high accuracy and high reliability.
  • In terms of regions, North America will remain the largest region over the forecast period due to rising rates of obesity, expensive medical care, new product introductions, and technology improvements in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Blood Glucose Monitoring System Market

The blood glucose monitoring system market has created current trends that are shaping its future. Here's an overview:

  • Continuous Glucose Monitoring: Currently, continuous glucose monitoring (CGM) systems are gaining more demand because they offer real-time glucose information and trends. These systems improve diabetes management by continuously presenting glucose levels, thereby reducing the need for multiple fingerstick tests.
  • Integration with Digital Health Platforms: There is an increasing trend of integrating glucose monitoring systems into digital health platforms and apps for better management, analysis, and communication between patients and healthcare professionals.
  • Non-Invasive Technologies: There is significant interest in the development of non-invasive glucose monitoring technologies. These technologies aim to provide accurate glucose measurements without requiring blood samples, making it easier and more comfortable for users.
  • Smartphone Connectivity: Monitors with smartphone connectivity are gaining momentum. These devices allow users to access their glucose levels and manage their data through various mobile applications, facilitating easy access and usability.
  • Affordability: The market is moving towards finding more affordable solutions for monitoring blood glucose. Lower-priced devices are making diabetes management more accessible in poorer and underdeveloped regions worldwide.

These trends act as catalysts for innovation, extending the use of blood glucose monitoring systems and enhancing their role in diabetes management and patient care.

Recent Developments in the Blood Glucose Monitoring System Market

There have been several key developments in the blood glucose monitoring system market. An overview follows:

  • Improving CGM: Continuous glucose monitoring systems now boast better accuracy and extended wear times, providing more detailed glucose data and better support for diabetes management.
  • Non-Invasive Monitoring: Non-invasive glucose monitoring technology is under development, with new devices emerging that reduce the pain and discomfort associated with traditional blood glucose testing.
  • Integration of Glucose Monitors with Mobile Health: Recent innovations include integrating glucose monitors with mobile health apps and platforms. These integrations enhance data tracking and improve interaction between patients and healthcare providers.
  • Cost-Effective Solutions: Novel blood glucose meters are being introduced with a focus on cost-effectiveness. These provide essential features at lower prices, increasing access among larger populations.
  • Improved Accuracy and Precision: Advances in sensor technology are enabling the development of more accurate and precise blood glucose monitoring systems, thereby increasing the reliability of glucose measurements and improving diabetes management.

These developments enhance the functionality of blood glucose monitoring systems by improving accuracy, access, and user convenience in diabetes management.

Strategic Growth Opportunities for Blood Glucose Monitoring System Market

From a strategic perspective, the blood glucose monitoring system market has numerous growth prospects within key applications. A brief overview follows:

  • Management of Diabetes: The adoption of advanced glucose monitoring systems for diabetes management presents a growing opportunity. These systems provide real-time data and insights to better control and treat diabetes.
  • Integration with Telehealth: Integrating blood glucose monitoring systems with telehealth platforms also opens up growth prospects. This enables remote monitoring and consultations, improving the quality of care and patient management.
  • Offering Monitoring Solutions at Affordable Prices: Developing affordable glucose monitoring devices for low-income and developing regions represents a significant growth opportunity. These solutions will broaden access to diabetes management tools and improve global health outcomes.
  • Wearable Technology: Integrating glucose monitoring systems with wearable technology opens potential avenues for growth. Wearable devices support continuous glucose monitoring along with other health metrics, facilitating comprehensive health management.
  • Personalized Medicine: There are growth opportunities in glucose monitoring data that support personalized medicine. Tailoring diabetes management to individual glucose patterns and responses enhances treatment effectiveness and patient outcomes.

These emerging opportunities are fostering market growth and development, and improving the efficacy and reach of blood glucose monitoring systems.

Blood Glucose Monitoring System Market Driver and Challenges

The blood glucose monitoring system market is a growth market exhibiting possibilities for growth that are influenced by various technological, economic, and regulatory factors. A glance at the key drivers and challenges has been presented here:

The factors responsible for driving the blood glucose monitoring system market include:

  • Technological Advances: Improvement and innovation in monitoring technologies of glucose, both CGM and non-obtrusive, better the accuracy and convenience for the user. This acts as a driver to market growth.
  • Growing Diabetes Prevalence: The rise in global prevalence propels the growth in demand for effective glucose monitoring solutions, further supporting the market's expansion.
  • Integration into Digital Health: Glucose monitors are increasingly being integrated into digital health platforms, enhancing data management and patient engagement, hence assisting the market to grow.
  • More Emphasis on Personalization: Advancing personalized medicine and personalized treatment plans is driving the need for advanced glucose monitoring systems.
  • Affordable Solutions: The development of cost-effective glucose monitoring devices is expanding market access and driving growth in underserved regions.

Challenges in the blood glucose monitoring system market are:

  • High Costs: Advanced glucose monitoring systems are expensive, and their adoption is particularly low in low-income regions and among non-insured populations.
  • Regulatory Hurdles: Navigating regulatory approvals for new technologies can be complex and time-consuming, potentially delaying product launches and market entry.

These drivers and challenges will continue to influence the blood glucose monitoring system market and shape its growth trajectory and strategic decisions of the stakeholders.

List of Blood Glucose Monitoring System Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, blood glucose monitoring system companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the blood glucose monitoring system companies profiled in this report include-

  • Thermos Fisher Scientific
  • Promega
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • B.D.
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott

Blood Glucose Monitoring System by Segment

The study includes a forecast for the global blood glucose monitoring system market by testing site, product, patient care setting, application, and region.

Blood Glucose Monitoring System Market by Testing Site [Analysis by Value from 2019 to 2031]:

  • Fingertip
  • Alternate Site

Blood Glucose Monitoring System Market by Product [Analysis by Value from 2019 to 2031]:

  • Self-Monitoring
  • Continuous Glucose Monitoring Devices

Blood Glucose Monitoring System Market by Patient Care Setting [Analysis by Value from 2019 to 2031]:

  • Hospital
  • Homecare

Blood Glucose Monitoring System Market by Application [Analysis by Value from 2019 to 2031]:

  • Type 1
  • Type 2
  • Gestational Diabetes
  • Others

Blood Glucose Monitoring System Market by Region [Analysis by Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Blood Glucose Monitoring System Market

Blood glucose monitoring systems represent one of the fastest-growing markets, replacing conventional products with technologically advanced ones and increasing demand for diabetes management. Here is an overview of recent trends in major countries:

  • United States: The introduction of real-time continuous glucose monitoring systems that deliver real-time glucose readings marks a significant development in the U.S. market. Integration with smartphones and wearables is continuously modernizing user convenience for easier data access.
  • China: China remains a high-growth market due to the rising penetration of low-cost blood glucose meters and CGMs, driven by greater disease awareness and healthcare reforms. Innovations in lower-cost monitoring solutions are making diabetes management more accessible to a broader population.
  • Germany: Germany is progressing in developing non-invasive glucose monitoring technology and improving the accuracy of glucose testing. Ongoing research aims to increase the reliability of these systems and integrate them into digital health platforms for more effective diabetes management.
  • India: The market is expected to grow due to the introduction of more affordable blood glucose monitoring devices and increased access to continuous glucose monitoring. This will improve accessibility to diabetes management tools in both urban and rural settings.
  • Japan: Japan is at the forefront of integrating other health monitoring technologies into advanced glucose monitoring systems. Its focus is on developing systems capable of providing comprehensive health data, including glucose levels, for personalized treatment plans.

Features of the Global Blood Glucose Monitoring System Market

Market Size Estimates: Blood glucose monitoring system market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Blood glucose monitoring system market size by various segments, such as by testing site, product, patient care setting, application, and region in terms of value ($B).

Regional Analysis: Blood glucose monitoring system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different testing sites, products, patient care settings, applications, and regions for the blood glucose monitoring system market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the blood glucose monitoring system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M&A, and more.

This report answers the following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the blood glucose monitoring system market by testing site (fingertip and alternate site), product (self-monitoring and continuous glucose monitoring devices), patient care setting (hospital and homecare), application (type 1, type 2, gestational diabetes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Blood Glucose Monitoring System Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

  • 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
  • 3.2. Global Blood Glucose Monitoring System Market Trends (2019-2024) and Forecast (2025-2031)
  • 3.3: Global Blood Glucose Monitoring System Market by Testing Site
    • 3.3.1: Fingertip
    • 3.3.2: Alternate Site
  • 3.4: Global Blood Glucose Monitoring System Market by Product
    • 3.4.1: Self-Monitoring
    • 3.4.2: Continuous Glucose Monitoring Devices
  • 3.5: Global Blood Glucose Monitoring System Market by Patient Care Setting
    • 3.5.1: Hospital
    • 3.5.2: Homecare
  • 3.6: Global Blood Glucose Monitoring System Market by Application
    • 3.6.1: Type 1
    • 3.6.2: Type 2
    • 3.6.3: Gestational Diabetes
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

  • 4.1: Global Blood Glucose Monitoring System Market by Region
  • 4.2: North American Blood Glucose Monitoring System Market
    • 4.2.1: North American Market by Testing Site: Fingertip and Alternate Site
    • 4.2.2: North American Market by Patient Care Setting: Hospital and Homecare
  • 4.3: European Blood Glucose Monitoring System Market
    • 4.3.1: European Market by Testing Site: Fingertip and Alternate Site
    • 4.3.2: European Market by Patient Care Setting: Hospital and Homecare
  • 4.4: APAC Blood Glucose Monitoring System Market
    • 4.4.1: APAC Market by Testing Site: Fingertip and Alternate Site
    • 4.4.2: APAC Market by Patient Care Setting: Hospital and Homecare
  • 4.5: ROW Blood Glucose Monitoring System Market
    • 4.5.1: ROW Market by Testing Site: Fingertip and Alternate Site
    • 4.5.2: ROW Market by Patient Care Setting: Hospital and Homecare

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Testing Site
    • 6.1.2: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Product
    • 6.1.3: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Patient Care Setting
    • 6.1.4: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Application
    • 6.1.5: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Region
  • 6.2: Emerging Trends in the Global Blood Glucose Monitoring System Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Blood Glucose Monitoring System Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Blood Glucose Monitoring System Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermos Fisher Scientific
  • 7.2: Promega
  • 7.3: Agilent Technologies
  • 7.4: Bio-Rad Laboratories
  • 7.5: QIAGEN
  • 7.6: Merck
  • 7.7: B.D.
  • 7.8: Sanofi
  • 7.9: Ascensia Diabetes Care Holdings
  • 7.10: Abbott